Elevated C-Reactive Protein as a Potential Biomarker for Neurological Adverse Events in Immune Checkpoint Inhibitor Therapy: A Prospective Cohort Study. - Duzzi L; Möhn N; Narten E; Thomas J; Mahjoub S; Grote-Levi L; Jendretzky K; Nay S; Konen F; Wiegmann J; Beutel G; Fröhlich T; et al. (Oncology research, 2026)